November 22nd 2024
On the most recent episode of Over the Counter, James Rider, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.
Pharmacists, FTC debate during hearing on anti-trust immunity
April 3rd 2012Should independent pharmacies be given anti-trust immunity to act against contracts presented by pharmacy benefit managers? A representative of the Federal Trade Commission said ?no? and pharmacists said ?yes? during a Congressional subcommittee hearing on HR 1946 last week.
Retail pharmacists vow to keep fighting after Express Scripts-Medco merger approved
April 2nd 2012The Federal Trade Commission (FTC) approved the $29.1 billion merger of Express Scripts and Medco Health Solutions on Monday, but the retail pharmacy industry continues to fight the deal, vowing to push a request for a temporary restraining order (TRO) that it filed on Friday.
Community pharmacies file suit to block merger of Express Scripts, Medco
March 29th 2012The National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association, and 9 retail pharmacy companies filed a lawsuit Thursday to stop the proposed merger of pharmacy benefit manager giants Express Scripts and Medco Health Solutions.
Enhanced pharmacist care improves LDL in patients with dyslipidemia
March 29th 2012Enhanced pharmacist care for patients with dyslipidemia improves low-density lipoprotein cholesterol levels, according to a study published in the March issue of Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
FDA adds new label warnings for the antidepressant citalopram
March 28th 2012FDA added new label warnings for the antidepressant citalopram (Celexa, Forest Laboratories), discouraging patients with certain conditions from using the drug and lowering the dosage recommendations to 20 mg daily for patients aged 60 and older. The warning is also applicable to generic versions of Celexa.
FDA approves 'dry' nasal aerosol to treat allergy symptoms
March 26th 2012FDA has approved beclomethasone dipropionate (QNASL Nasal Aerosol, Teva Pharmaceutical Industries), a ?dry? nasal aerosol corticosteroid that treats year-round and seasonal nasal allergy symptoms in people aged 12 years and older.